Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2006Cancer ResearchOpen Access

Discovery and Evaluation of Dual CDK1 and CDK2 Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMarc PaytonAmgen (United States)GCGrace ChungAmgen (United States)PYP. YakowecCalifornia Institute of Technology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Payton et al. (2006) studied this question.

synapsesocial.com/papers/6a31916bc18c2d244f486d9ehttps://doi.org/10.1158/0008-5472.can-05-2507
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent2004 · 253 citations
  2. 2ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks2001 · 1,987 citations
  3. 3Cyclin E and Survival in Patients with Breast Cancer2002 · 559 citations